Concepedia
Statistics
Publications
8
Citations
378
H-Index
Active since
2007
Affiliations
GlaxoSmithKline (United Kingdom)(Current)
Molecular Discovery (United Kingdom)
University of Glasgow
University College London
University of Padua
Ben Powney is an author at GlaxoSmithKline (United Kingdom) specializing in drug discovery, medicine, and pharmacology.
Top concepts
MedicineBiochemistryPharmacologyDrug DiscoveryNatural SciencesPhysiologyGlycobiologyHuman GrowthEndocrinologySmall Molecules
Publications per year
2007–2017
Mitochondrial permeability transition pore: sensitivity to opening and mechanistic dependence on substrate availability
Thomas Briston, Malcolm C. Roberts, Siân Lewis et al. · Scientific Reports · 2017 · 141 citations · Full text
Protean Agonism at the Dopamine D2 Receptor: (S)-3-(3-Hydroxyphenyl)-N-propylpiperidine Is an Agonist for Activation of Go1 but an Antagonist/Inverse Agonist for Gi1,Gi2, and Gi3
J. Robert Lane, Ben Powney, Alan Wise et al. · Molecular Pharmacology · 2007 · 67 citations
G Protein Coupling and Ligand Selectivity of the D2L and D3 Dopamine Receptors
J. Robert Lane, Ben Powney, Alan Wise et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 62 citations
Identification of ER-000444793, a Cyclophilin D-independent inhibitor of mitochondrial permeability transition, using a high-throughput screen in cryopreserved mitochondria
Thomas Briston, Siân Lewis, Mumta Koglin et al. · Scientific Reports · 2016 · 30 citations · Full text
The identification of structurally novel, selective, orally bioavailable positive modulators of mGluR2
Pier Luca D’Alessandro, Corrado Corti, Adelheid Roth et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 23 citations · Full text
Medicinal Chemistry, Biochemistry, Natural Sciences +6
1–5 of 8